SUDEEPPHRM quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Sudeep Pharma Ltd reported sales of ₹197 Cr, operating profit of ₹73 Cr (OPM 37%) and net profit of ₹52 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
SUDEEPPHRM quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
116
158
125
163
172
182
158
197
Expenses
76
99
81
107
112
120
103
123
Operating Profit
39
59
44
55
60
63
55
73
OPM
34%
37%
35%
34%
35%
34%
35%
37%
Other Income
2
4
5
10
7
6
5
6
Interest
1
2
2
2
1
2
2
3
Depreciation
3
3
3
4
4
4
4
5
Profit before tax
38
58
44
60
62
63
54
71
Tax
24%
24%
29%
21%
23%
23%
25%
27%
Net Profit
29
44
31
47
48
49
41
52
EPS in Rs
2.95
4.54
3.17
4.71
4.2
4.33
3.59
4.56
SUDEEPPHRM profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
343
429
459
502
642
710
Expenses
276
338
276
310
419
459
Operating Profit
67
90
183
192
223
251
OPM
20%
21%
40%
38%
35%
35%
Other Income
7
9
6
9
28
25
Interest
2
6
5
7
8
8
Depreciation
5
8
9
11
15
17
Profit before tax
69
86
175
183
228
250
Tax
27%
28%
24%
24%
24%
-
Net Profit
50
62
133
139
174
189
EPS in Rs
5.97
7.42
15.86
14.27
15.31
16.68
Dividend Payout
0%
0%
0%
0%
0%
-
SUDEEPPHRM balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
1
10
10
11
11
Reserves
355
481
715
872
946
Borrowings
78
140
143
150
189
Other Liabilities
80
86
121
141
182
Total Liabilities
514
717
988
1,174
1,329
Fixed Assets
180
189
299
337
524
CWIP
45
88
126
185
54
Investments
0
0
0
0
0
Other Assets
289
439
562
652
751
Total Assets
514
717
988
1,174
1,329
SUDEEPPHRM cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
-3
48
66
49
70
Cash from Investing Activity
-38
-50
-49
-79
-327
Cash from Financing Activity
51
-10
-13
53
247
Net Cash Flow
10
-11
4
23
-10
Free Cash Flow
-77
1
13
-15
-49
CFO/OP
22%
78%
60%
47%
56%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit